Medical cannabis group Cilo Cybin has halted the production and supply of its cannabidiol (CBD) range for the South African market amid continued regulatory challenges over the trade in cannabis.

The company, which listed on the JSE's Alternative Exchange in June last year, is now focused on exporting its CBD products to Australia and countries such as Germany...

Subscribe now to unlock this article.

Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).

There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.

Cancel anytime.

Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.

Speech Bubbles

Please read our Comment Policy before commenting.